Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

Share Price is delayed by 15 minutes
Get Live Data
1,143.50    5.00 (0.44%)
Bid:
1,144.00
Ask:
1,144.50
Spread: 0.50 (0.044%)
Market Cap: £9.66b
SN. Live PriceLast checked at - London Stock Exchange

Intraday Smith & Nephew Share Chart

Transaction in Own Shares

3 May 2019 11:37

RNS Number : 0497Y
Smith & Nephew Plc
03 May 2019
Β 

3 May 2019

Β 

Smith & Nephew plc (the "Company")

Β 

Commencement of Quarterly Buy Back Programme

Β 

The Company will now commence its Quarterly Buy Back Programme of 1,155,996 of its ordinary shares of US 20Β’ each (the "Buy Back Programme") and has entered into an agreement with J.P. Morgan Securities plc ("JPMS") under which it has issued an irrevocable instruction to JPMS to manage the Buy Back Programme.

Β 

The Company intends to hold these shares in Treasury and then cancel them.

Β 

These shares were used in connection with employee share schemes in Quarter 1 2019.

Β 

The purpose of this Buy Back Programme is to reduce the share capital of the Company, in order to keep it broadly constant. The maximum pecuniary amount allocated to the Buy Back Programme is Β£18,500,000 and the maximum number of shares that will be purchased under the Buy Back Programme is 1,155,996. The Buy Back Programme will commence on 7 May 2019 and will end no later than 14 May 2019.

Β 

This announcement is made in accordance with Chapter 12 of the UKLA Listing Rules and Market Abuse Regulation 596/2014.

Β 

Β 

Susan Swabey

Company Secretary

Smith & Nephew plc

Tel: 01923 477216

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
POSSSLFSDFUSEDI
Date   Source Headline
26th Jun 20269:54 amRNSTransaction in Own Shares
26th Jun 20269:52 amRNSHolding(s) in Company
19th Jun 20269:21 amRNSTransaction in Own Shares
17th Jun 20269:03 amRNSHolding(s) in Company
12th Jun 202610:18 amRNSTransaction in Own Shares
11th Jun 20268:42 amRNSHolding(s) in Company
5th Jun 202612:12 pmRNSTransaction in Own Shares
4th Jun 20264:05 pmRNSDirector/PDMR Shareholding
3rd Jun 202611:21 amRNSDirector/PDMR Shareholding
3rd Jun 202610:35 amRNSAdmission to Trading
1st Jun 20263:10 pmRNSTotal Voting Rights
29th May 202610:37 amRNSTransaction in Own Shares
27th May 20269:31 amRNSPre Stabilisation Notice
22nd May 20261:32 pmRNSAdmission to Trading
22nd May 20269:58 amRNSTransaction in Own Shares
20th May 202611:25 amRNSDirector/PDMR Shareholding
19th May 20268:53 amRNSHolding(s) in Company
15th May 202612:28 pmRNSTransaction in Own Shares Replacement
15th May 202611:41 amRNSTransaction in Own Shares
14th May 20269:25 amRNSHolding(s) in Company
12th May 20264:03 pmRNSSterling Amount of Dividend
8th May 20267:00 amRNSShare Buyback Programme
6th May 20262:25 pmRNSResult of AGM
6th May 20267:00 amRNSSmith+Nephew First Quarter 2026 Trading Update
1st May 20261:10 pmRNSTotal Voting Rights
27th Apr 20267:00 amRNSExpert surgeons insights event for investors
22nd Apr 20268:46 amRNSNotice of Results
16th Apr 202611:12 amRNSDirector/PDMR Shareholding
15th Apr 20263:46 pmRNSDirector Declaration
14th Apr 20262:59 pmRNSReplacement: Annual Financial Report & AGM Notice
1st Apr 202612:23 pmRNSTotal Voting Rights
24th Mar 20264:16 pmRNSDirector/PDMR Shareholding
24th Mar 20268:45 amRNSHolding(s) in Company
16th Mar 20263:08 pmRNSAnnual Financial Report & Notice of AGM
16th Mar 20263:08 pmRNSAnnual Financial Report & Notice of AGM
10th Mar 20262:30 pmRNS-RSmith+Nephew launches next-generation ALLEVYN™ COMPLETE CARE Foam Dressing - designed for high performance in wound management and pressure injury prevention
5th Mar 20267:30 amRNSDirector Declaration
2nd Mar 20261:36 pmRNSTotal Voting Rights
2nd Mar 20267:00 amRNSFinal Results
5th Feb 202611:56 amRNSNotice of Results
2nd Feb 20264:00 pmRNSBLOCK LISTING SIX MONTHLY RETURN
2nd Feb 20263:05 pmRNSTotal Voting Rights
23rd Jan 20262:00 pmRNSDirector/PDMR Shareholding
21st Jan 20264:11 pmRNSCompletion of Acquisition
12th Jan 20264:30 pmRNSAcquisition of Integrity Orthopaedics
2nd Jan 202610:07 amRNSTotal Voting Rights
8th Dec 20257:00 amRNSNew Strategy and 2028 Financial Targets
1st Dec 20254:10 pmRNSTotal Voting Rights
19th Nov 202510:00 amRNSDirector/PDMR Shareholding
18th Nov 202510:18 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.